{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:09:50Z","timestamp":1789175390015,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11606-026-10423-5","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:25:35Z","timestamp":1776713135000},"page":"3499-3507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Atherosclerotic Cardiovascular Disease Risk-Enhancing Factors and Their Association with Primary Prevention Statin Use"],"prefix":"10.1007","volume":"41","author":[{"given":"Linnea M.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmony R.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5384-275X","authenticated-orcid":false,"given":"Timothy S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"8","key":"10423_CR1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamainternmed.2024.1302","volume":"184","author":"TS Anderson","year":"2024","unstructured":"Anderson TS, Wilson LM, Sussman JB. Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations. JAMA Intern Med. 2024;184(8):963\u2013970.","journal-title":"JAMA Intern Med."},{"key":"10423_CR2","doi-asserted-by":"publisher","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O\u2019Donnell CJ, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2014;63(25, pt B):2935\u20132959. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.005","DOI":"10.1016\/j.jacc.2013.11.005"},{"issue":"24","key":"10423_CR3","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1161\/CIR.0000000000000625","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino K, Forman DE, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circ. 2019;73(24):e285-e350. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","journal-title":"Circ."},{"key":"10423_CR4","doi-asserted-by":"publisher","unstructured":"Akintoye E, Afonso L, Jayanna MB Bao W, Briasoulis A, Robinson J. Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC\/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts. J Am Heart Assoc. 2021;10(12):e019589. https:\/\/doi.org\/10.1161\/JAHA.120.019589","DOI":"10.1161\/JAHA.120.019589"},{"key":"10423_CR5","doi-asserted-by":"publisher","unstructured":"Zhang Y, An J, Xia M, Zhou H, Sun Y, Chung J, Zhou M, Choi SK, Morrissette KL, Muntner P, et al. Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease. PLoS One. 2924;19(10):e0312756. https:\/\/doi.org\/10.1371\/journal.pone.0312756","DOI":"10.1371\/journal.pone.0312756"},{"key":"10423_CR6","doi-asserted-by":"publisher","unstructured":"Shah H, Garaccu Em Behuria S, Cainzos-Achirica M, Kandula NR, Kanaya AM, Shah NS. Cardiovascular risk-enhancing factors and coronary artery calcium in South Asian American adults: The MASALA study. Am J Prev Cardiol. 2022;13:100453. https:\/\/doi.org\/10.1016\/j.ajpc.2022.100453","DOI":"10.1016\/j.ajpc.2022.100453"},{"key":"10423_CR7","unstructured":"Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey. Updated May 21, 2023. Accessed February 10, 2025. https:\/\/www.cdc.gov\/nchs\/nhanes\/about_nhanes.htm"},{"key":"10423_CR8","doi-asserted-by":"crossref","unstructured":"Akinbami LJ, Chen TC, Davy O, Ogden CL, Fink S, Clark J, Riddles MK, Mohadjer LK. National Health and Nutrition Examination Survey, 2017\u2013March 2020 prepandemic file: sample design, estimation, and analytic guidelines. \ufeffVital Health Stat 1. 2022;(190):1\u201336.","DOI":"10.15620\/cdc:115434"},{"issue":"1","key":"10423_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/heq.2023.0038","volume":"8","author":"K Charles","year":"2024","unstructured":"Charles K, Lewis MJ, Montgomery E, Reid M. The 2021 Chronic Kidney Disease Epidemiology Collaboration race-free estimated glomerular filtration rate equations in kidney disease: leading the way in ending disparities. Health Equity. 2024;8 (1):39-45. https:\/\/doi.org\/10.1089\/heq.2023.0038","journal-title":"Health Equity."},{"key":"10423_CR10","unstructured":"American College of Cardiology. ASCVD Risk Estimator. Accessed February 12, 2025.https:\/\/tools.acc.org\/ldl\/ascvd_risk_estimator\/index.html#!\/calulate\/estimator\/"},{"key":"10423_CR11","doi-asserted-by":"publisher","unstructured":"Naci\u202fH\ufeff, Brugts\u202fJJ\ufeff, Fleurence R\ufeff, Ades AE\ufeff.\u202fDose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials.\u202fEur J Prev Cardiol. 2013;20(4):658\u2013670. https:\/\/doi.org\/10.1177\/2047487313483600","DOI":"10.1177\/2047487313483600"},{"key":"10423_CR12","doi-asserted-by":"publisher","unstructured":"Adams SP\ufeff, Alaeiilkhchi N\ufeff, Wright JM\ufeff. Pitavastatin for lowering lipids.\u202f\ufeff\u202fCochrane Database Syst Rev. 2020;6(6):CD012735. https:\/\/doi.org\/10.1002\/14651858.CD01735.pub2","DOI":"10.1002\/14651858.CD01735.pub2"},{"key":"10423_CR13","doi-asserted-by":"publisher","unstructured":"Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW; STELLAR Study Group. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003;92:152\u2013160. https:\/\/doi.org\/10.1016\/S0002-9149(03)00530-7","DOI":"10.1016\/S0002-9149(03)00530-7"},{"issue":"7","key":"10423_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1056\/NEJM199908123410707","volume":"341","author":"RH Knopp","year":"1999","unstructured":"Knopp RH. Drug treatment of lipid disorders. New Engl J Med. 1999;341(7):498-511. https:\/\/doi.org\/10.1056\/NEJM199908123410707","journal-title":"New Engl J Med."},{"issue":"12","key":"10423_CR15","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.7326\/M23-1915","volume":"176","author":"CJ Kim","year":"2023","unstructured":"Kim CJ, Sussman JB, Mukamal K, Eades M, Anderson TS. Trends in primary prevention statin use by cardiovascular risk score from 1999 to 2018: A repeated cross-sectional study. Ann Intern Med. 2023;176(12):1684-1688. https:\/\/doi.org\/10.7326\/M23-1915","journal-title":"Ann Intern Med."},{"key":"10423_CR16","unstructured":"Norton EC, Dowd BE, Maciejewski ML. Marginal Effects\u2014Quantifying the Effect of Changes in Risk Factors in Logistic Regression Models. In: Livingston EH, Lewis RJ. eds. JAMA Guide to Statistics and Methods. McGraw-Hill Education; 2019. Accessed April 04, 2025. https:\/\/jamaevidence.mhmedical.com\/content.aspx?bookid=2742&sectionid=233568067"},{"issue":"1","key":"10423_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jacl.2021.11.009","volume":"16","author":"GL Vega","year":"2022","unstructured":"Vega GL, Wang J, Grundy SM. Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease. J Clin Lipidol. 2022;16(1):66-74. https:\/\/doi.org\/10.1016\/j.jacl.2021.11.009","journal-title":"J Clin Lipidol."},{"issue":"10","key":"10423_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/jamacardio.2021.2321","volume":"6","author":"J Patel","year":"2021","unstructured":"Patel J, Pallazola VA, Dudum R, Greenland P, McEvoy JW, Blumenthal RS, Virani SS, Miedema MD, Shea S, Yeboah J, et al. Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors: The Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2021;6(10):1161-1170. https:\/\/doi.org\/10.1001\/jamacardio.2021.2321","journal-title":"JAMA Cardiol."},{"issue":"11","key":"10423_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.006078","volume":"12","author":"RH Stern","year":"2019","unstructured":"Stern RH, Brook RD. Do risk-enhancing factors enhance risk estimation? Circ Cardiovasc Qual Outcomes. 2019;12(11):e006078. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.006078","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"10423_CR20","unstructured":"Connolly J, Troy AL, Blumenthal RS, Stone NJ. Consider the whole picture: Risk-enhancing factors and clinician decision-making. American College of Cardiology. Published 2025. Accessed March 30, 2025. https:\/\/www.acc.org\/Latest-in-Cardiology\/Articles\/2025\/02\/20\/17\/47\/Consider-the-Whole-Picture?utm_medium=social&utm_source=twitter_post&utm_campaign=twitter_post"},{"issue":"3","key":"10423_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jama.2018.4242","volume":"320","author":"JS Lin","year":"2018","unstructured":"Lin JS, Evans CV, Johnson E, Redmond N, Coppola EL, Smith N. Nontraditional risk factors in cardiovascular disease risk assessment: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320(3):281-297. https:\/\/doi.org\/10.1001\/jama.2018.4242","journal-title":"JAMA."},{"issue":"7","key":"10423_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12170-019-0616-y","volume":"13","author":"A Agarwala","year":"2019","unstructured":"Agarwala A, Liu K, Ballantyne CM, Virani SS. The use of risk-enhancing factors to personalize ASCVD risk assessment: Evidence and recommendations from the 2018 AHA\/ACC multi-society cholesterol guidelines. Curr Cardiovasc Risk Rep. 2019;13(7):18. https:\/\/doi.org\/10.1007\/s12170-019-0616-y","journal-title":"Curr Cardiovasc Risk Rep."},{"key":"10423_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Spronston","year":"2018","unstructured":"Spronston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. https:\/\/doi.org\/10.3389\/fimmu.2018.00754","journal-title":"Front Immunol."},{"key":"10423_CR24","doi-asserted-by":"publisher","unstructured":"Khan SS, Matshushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E; Chronic Kidney Disease Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and validation of the American Heart Association\u2019s PREVENT equations. Circulation. 2024;149(6):430\u2013449. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067626","DOI":"10.1161\/CIRCULATIONAHA.123.067626"},{"key":"10423_CR25","doi-asserted-by":"publisher","unstructured":"Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC, Sperling LS, Virani SS, Blumenthal RS. Use of risk assessment tools to guide decision-making in the primary prevention for atherosclerotic cardiovascular disease: A special report from the American Heart Assocaition and American College of Cardiology. J Am Coll Cardiol. 2019;73(24):3153-3167. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.005","DOI":"10.1016\/j.jacc.2018.11.005"},{"key":"10423_CR26","doi-asserted-by":"publisher","unstructured":"DeWitt CM, Ponce RB, Bry H, Wali S, Sedlander E, Ladapo JA. Patient-reported reasons for not using primary prevention statin therapy. J Clin Med. 2020;9:3337. https:\/\/doi.org\/10.3390\/jcm9103337","DOI":"10.3390\/jcm9103337"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10423-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:02:02Z","timestamp":1789174922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10423"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10423-5","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This cross-sectional study was exempt from review and informed consent by the Common Rule given the use of publicly available data.","order":2,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Anderson reports receiving grants from the Department of Veterans Affairs, National Institute on Aging, and American Heart Association as well as personal fees from the American Medical Association for serving as an Associate Editor at JAMA Internal Medicine and consulting fees from American Medical Student Association outside the submitted work. Ms. Wilson reports receiving personal fees from the American Medical Student Association outside the submitted work. Dr. Sussman reports grants from the Department of Veterans Affairs and National Institutes of Health outside of the submitted work. Dr. Reynolds reports receiving grants from the National Institutes of Health and the American Heart Association, in kind research donations from Abbott Vascular, Siemens and SHL Telemedicine, and consulting fees from Heartflow, all outside the submitted work.","order":3,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}